Staffing & Employment Services
Compare Stocks
4 / 10Stock Comparison
IPDN vs KFRC vs CCRN vs TASK
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Medical - Care Facilities
Information Technology Services
IPDN vs KFRC vs CCRN vs TASK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Staffing & Employment Services | Staffing & Employment Services | Medical - Care Facilities | Information Technology Services |
| Market Cap | $943K | $790M | $423M | $573M |
| Revenue (TTM) | $6M | $1.33B | $761M | $1.21B |
| Net Income (TTM) | $-2.36B | $35M | $-99M | $105M |
| Gross Margin | 44.1% | 27.2% | 18.2% | 35.5% |
| Operating Margin | -136.0% | 3.8% | -0.9% | 11.6% |
| Forward P/E | — | 18.0x | 133.8x | 4.6x |
| Total Debt | $279K | $70M | $2M | $298M |
| Cash & Equiv. | $2M | $2M | $109M | $212M |
IPDN vs KFRC vs CCRN vs TASK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Professional Divers… (IPDN) | 100 | 2.3 | -97.7% |
| Kforce Inc. (KFRC) | 100 | 68.7 | -31.3% |
| Cross Country Healt… (CCRN) | 100 | 79.3 | -20.7% |
| TaskUs, Inc. (TASK) | 100 | 18.6 | -81.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPDN vs KFRC vs CCRN vs TASK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPDN plays a supporting role in this comparison — it may shine differently against other peers.
KFRC is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 8 yrs, beta 0.53, yield 3.6%
- 195.5% 10Y total return vs CCRN's -10.5%
- Beta 0.53 vs IPDN's 1.35
- 3.6% yield; 8-year raise streak; the other 3 pay no meaningful dividend
CCRN is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
- Beta 0.78, current ratio 3.78x
TASK carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 19.0%, EPS growth 120.0%, 3Y rev CAGR 7.2%
- 19.0% revenue growth vs CCRN's -21.6%
- Lower P/E (4.6x vs 133.8x)
- 8.7% margin vs IPDN's -135.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.0% revenue growth vs CCRN's -21.6% | |
| Value | Lower P/E (4.6x vs 133.8x) | |
| Quality / Margins | 8.7% margin vs IPDN's -135.9% | |
| Stability / Safety | Beta 0.53 vs IPDN's 1.35 | |
| Dividends | 3.6% yield; 8-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +18.9% vs IPDN's -55.4% | |
| Efficiency (ROA) | 10.3% ROA vs IPDN's -194.3%, ROIC 16.3% vs -68.4% |
IPDN vs KFRC vs CCRN vs TASK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IPDN vs KFRC vs CCRN vs TASK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KFRC leads in 3 of 6 categories
TASK leads 2 • IPDN leads 0 • CCRN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TASK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KFRC is the larger business by revenue, generating $1.3B annually — 209.2x IPDN's $6M. TASK is the more profitable business, keeping 8.7% of every revenue dollar as net income compared to IPDN's -135.9%. On growth, IPDN holds the edge at +1021.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6M | $1.3B | $761M | $1.2B |
| EBITDAEarnings before interest/tax | -$2.3B | $56M | $9M | $204M |
| Net IncomeAfter-tax profit | -$2.4B | $35M | -$99M | $105M |
| Free Cash FlowCash after capex | -$5M | $43M | $41M | $88M |
| Gross MarginGross profit ÷ Revenue | +44.1% | +27.2% | +18.2% | +35.5% |
| Operating MarginEBIT ÷ Revenue | -136.0% | +3.8% | -0.9% | +11.6% |
| Net MarginNet income ÷ Revenue | -135.9% | +2.6% | -13.0% | +8.7% |
| FCF MarginFCF ÷ Revenue | -0.3% | +3.3% | +5.4% | +7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1021.2% | +0.1% | -100.0% | +10.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -26026.4% | +2.2% | -6.0% | +13.0% |
Valuation Metrics
TASK leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 5.8x trailing earnings, TASK trades at a 74% valuation discount to KFRC's 22.1x P/E. On an enterprise value basis, TASK's 3.3x EV/EBITDA is more attractive than CCRN's 23.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $942,982 | $790M | $423M | $573M |
| Enterprise ValueMkt cap + debt − cash | -$508,861 | $858M | $317M | $660M |
| Trailing P/EPrice ÷ TTM EPS | -0.37x | 22.05x | -4.47x | 5.79x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.96x | 133.84x | 4.58x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.23x |
| EV / EBITDAEnterprise value multiple | — | 15.42x | 23.75x | 3.26x |
| Price / SalesMarket cap ÷ Revenue | 0.14x | 0.59x | 0.40x | 0.48x |
| Price / BookPrice ÷ Book value/share | 0.19x | 6.17x | 1.31x | 0.99x |
| Price / FCFMarket cap ÷ FCF | — | 16.88x | 10.55x | 7.78x |
Profitability & Efficiency
Evenly matched — KFRC and TASK each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
KFRC delivers a 27.2% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-284 for IPDN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to KFRC's 0.56x. On the Piotroski fundamental quality scale (0–9), TASK scores 7/9 vs KFRC's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -284.3% | +27.2% | -27.1% | +21.2% |
| ROA (TTM)Return on assets | -194.3% | +9.2% | -19.8% | +10.3% |
| ROICReturn on invested capital | -68.4% | +19.1% | -0.9% | +16.3% |
| ROCEReturn on capital employed | -65.9% | +20.1% | -0.8% | +16.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.06x | 0.56x | 0.01x | 0.50x |
| Net DebtTotal debt minus cash | -$1M | $68M | -$106M | $86M |
| Cash & Equiv.Liquid assets | $2M | $2M | $109M | $212M |
| Total DebtShort + long-term debt | $279,312 | $70M | $2M | $298M |
| Interest CoverageEBIT ÷ Interest expense | -66476.01x | — | -1.39x | 7.12x |
Total Returns (Dividends Reinvested)
KFRC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KFRC five years ago would be worth $8,325 today (with dividends reinvested), compared to $235 for IPDN. Over the past 12 months, KFRC leads with a +18.9% total return vs IPDN's -55.4%. The 3-year compound annual growth rate (CAGR) favors KFRC at -4.8% vs IPDN's -74.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -43.4% | +39.2% | +62.4% | -12.3% |
| 1-Year ReturnPast 12 months | -55.4% | +18.9% | -5.4% | -28.3% |
| 3-Year ReturnCumulative with dividends | -98.4% | -13.8% | -44.3% | -18.1% |
| 5-Year ReturnCumulative with dividends | -97.6% | -16.8% | -22.5% | -67.8% |
| 10-Year ReturnCumulative with dividends | -99.1% | +195.5% | -10.5% | -67.8% |
| CAGR (3Y)Annualised 3-year return | -74.9% | -4.8% | -17.7% | -6.4% |
Risk & Volatility
KFRC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KFRC is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than IPDN's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KFRC currently trades 91.0% from its 52-week high vs IPDN's 6.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.35x | 0.53x | 0.78x | 1.12x |
| 52-Week HighHighest price in past year | $12.39 | $47.48 | $14.99 | $18.39 |
| 52-Week LowLowest price in past year | $0.68 | $24.49 | $7.43 | $5.89 |
| % of 52W HighCurrent price vs 52-week peak | +6.1% | +91.0% | +87.3% | +34.6% |
| RSI (14)Momentum oscillator 0–100 | 36.8 | 65.6 | 53.1 | 42.0 |
| Avg Volume (50D)Average daily shares traded | 80K | 305K | 552K | 736K |
Analyst Outlook
KFRC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: KFRC as "Hold", CCRN as "Hold", TASK as "Buy". Consensus price targets imply 111.9% upside for TASK (target: $14) vs -18.9% for CCRN (target: $11). KFRC is the only dividend payer here at 3.58% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $71.00 | $10.61 | $13.50 |
| # AnalystsCovering analysts | — | 10 | 14 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +3.6% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 8 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $1.55 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +6.4% | +1.6% | +4.8% |
KFRC leads in 3 of 6 categories (Total Returns, Risk & Volatility). TASK leads in 2 (Income & Cash Flow, Valuation Metrics). 1 tied.
IPDN vs KFRC vs CCRN vs TASK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IPDN or KFRC or CCRN or TASK a better buy right now?
For growth investors, TaskUs, Inc.
(TASK) is the stronger pick with 19. 0% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). TaskUs, Inc. (TASK) offers the better valuation at 5. 8x trailing P/E (4. 6x forward), making it the more compelling value choice. Analysts rate TaskUs, Inc. (TASK) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IPDN or KFRC or CCRN or TASK?
On trailing P/E, TaskUs, Inc.
(TASK) is the cheapest at 5. 8x versus Kforce Inc. at 22. 1x. On forward P/E, TaskUs, Inc. is actually cheaper at 4. 6x.
03Which is the better long-term investment — IPDN or KFRC or CCRN or TASK?
Over the past 5 years, Kforce Inc.
(KFRC) delivered a total return of -16. 8%, compared to -97. 6% for Professional Diversity Network, Inc. (IPDN). Over 10 years, the gap is even starker: KFRC returned +195. 5% versus IPDN's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IPDN or KFRC or CCRN or TASK?
By beta (market sensitivity over 5 years), Kforce Inc.
(KFRC) is the lower-risk stock at 0. 53β versus Professional Diversity Network, Inc. 's 1. 35β — meaning IPDN is approximately 156% more volatile than KFRC relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 56% for Kforce Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IPDN or KFRC or CCRN or TASK?
By revenue growth (latest reported year), TaskUs, Inc.
(TASK) is pulling ahead at 19. 0% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TaskUs, Inc. grew EPS 120. 0% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, TASK leads at 7. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IPDN or KFRC or CCRN or TASK?
TaskUs, Inc.
(TASK) is the more profitable company, earning 8. 6% net margin versus -37. 3% for Professional Diversity Network, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TASK leads at 11. 9% versus -38. 6% for IPDN. At the gross margin level — before operating expenses — IPDN leads at 60. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IPDN or KFRC or CCRN or TASK more undervalued right now?
On forward earnings alone, TaskUs, Inc.
(TASK) trades at 4. 6x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 129. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TASK: 111. 9% to $13. 50.
08Which pays a better dividend — IPDN or KFRC or CCRN or TASK?
In this comparison, KFRC (3.
6% yield) pays a dividend. IPDN, CCRN, TASK do not pay a meaningful dividend and should not be held primarily for income.
09Is IPDN or KFRC or CCRN or TASK better for a retirement portfolio?
For long-horizon retirement investors, Kforce Inc.
(KFRC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53), 3. 6% yield, +195. 5% 10Y return). Both have compounded well over 10 years (KFRC: +195. 5%, IPDN: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IPDN and KFRC and CCRN and TASK?
These companies operate in different sectors (IPDN (Industrials) and KFRC (Industrials) and CCRN (Healthcare) and TASK (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IPDN is a small-cap quality compounder stock; KFRC is a small-cap income-oriented stock; CCRN is a small-cap quality compounder stock; TASK is a small-cap high-growth stock. KFRC pays a dividend while IPDN, CCRN, TASK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.